A Biospecimen Repository for Neurodegenerative Disease Research in Cooperation with the National Cell Repository for Alzheimer Disease
About this study
The purpose of this study is to collect clinical data, serial blood samples for plasma, serum, DNA and RNA extraction, and a single time blood sample for peripheral blood monocytes for the preparation of stem cell lines and lymphocytes for the preparation of lymphoblastoid cell lines. There will also be a single time skin biopsy sample for tissue examination and preparation of skin fibroblasts from patients who have familial or sporadic ALS, ALS-FTD or similar neurodegenerative motor neuron disorders, and are participating in NINDS funded research projects in the Mayo Clinic ALS Center.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Age > 18 years
- Has a clinical diagnosis of ALS or ALS-FTD
- Previously enrolled in ongoing DNA banking study
- Was evaluated regarding carrier status for a C9ORF72 repeat expansion
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.
|Mayo Clinic Location
Mayo Clinic principal investigator
Bjorn Oskarsson, M.D.
Closed for enrollment